Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M211Revenue $M14.1Net Margin (%)-252.2Z-Score-2.2
Enterprise Value $M152EPS $-0.9Operating Margin %-252.6F-Score1
P/E(ttm))0Cash Flow Per Share $0.4Pre-tax Margin (%)-252.2Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %0Quick Ratio10.9Cash flow > EarningsY
Price/Sales10.55-y EBITDA Growth Rate %0Current Ratio6.4Lower Leverage y-yN
Price/Cash Flow6.4y-y EBITDA Growth Rate %-240.9ROA % (ttm)-46.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-53.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M51.1ROI % (ttm)-80.2Gross Margin Increase y-yN

Gurus Latest Trades with PGNX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXJohn Hussman 2009-06-30 Sold Out -0.02%$4.53 - $6.84
($5.48)
$ 3.91-29%Sold Out0
PGNXJohn Hussman 2008-09-30 Buy 0.04%$12.19 - $17.07
($14.9)
$ 3.91-74%New holding, 100000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Baker Mark RobertCEO 2013-03-27Buy650$5.32-24.44view
Baker Mark RobertCEO 2013-02-27Buy1,262$2.7247.79view
Baker Mark RobertCEO 2013-01-22Buy1,215$2.8242.55view
Baker Mark RobertCEO 2012-12-26Buy1,142$3.0133.55view
Baker Mark RobertCEO 2012-11-28Buy1,607$2.1388.73view
Baker Mark RobertCEO 2012-11-19Buy11,800$1.96105.1view
Baker Mark RobertCEO 2012-11-16Buy49,793$1.82120.88view
Baker Mark RobertCEO 2012-11-15Buy48,833$1.69137.87view
Baker Mark RobertCEO 2012-10-24Buy1,162$2.9635.81view
Baker Mark RobertCEO 2012-09-26Buy1,036$3.3221.08view

Press Releases about PGNX:

Quarterly/Annual Reports about PGNX:

News about PGNX:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Oct 04 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Sep 02 2010 
Absolute Return on Paul Tudor Jones; Tudor Top Holdings: CISG, SPY, QQQQ, USO, PGNX Sep 02 2010 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK